Heinrich JN - Search Results

1

Biological activity of the growth factor-induced cytokine N51: structure-function analysis using N51/Interleukin-8 chimeric molecules.

Heinrich JN, O'Rourke EC, Chen L, Gray H, Dorfman KS, Bravo R. Heinrich JN, et al. Mol Cell Biol. 1994 May;14(5):2849-61. doi: 10.1128/mcb.14.5.2849-2861.1994. Mol Cell Biol. 1994. PMID: 8164648 Free PMC article.

2

N51 competes 125I-interleukin (IL)-8 binding to IL-8R beta but not IL-8R alpha. Structure-function analysis using N51/IL-8 chimeric molecules.

Heinrich JN, Bravo R. Heinrich JN, et al. J Biol Chem. 1995 Nov 24;270(47):28014-7. doi: 10.1074/jbc.270.47.28014. J Biol Chem. 1995. PMID: 7499284 Free article.

3

The orphan mouse receptor interleukin (IL)-8R beta binds N51. Structure-function analysis using N51/IL-8 chimeric molecules.

Heinrich JN, Bravo R. Heinrich JN, et al. J Biol Chem. 1995 Mar 10;270(10):4987-9. doi: 10.1074/jbc.270.10.4987. J Biol Chem. 1995. PMID: 7890604 Free article.

4

The product of a novel growth factor-activated gene, fic, is a biologically active "C-C"-type cytokine.

Heinrich JN, Ryseck RP, Macdonald-Bravo H, Bravo R. Heinrich JN, et al. Mol Cell Biol. 1993 Apr;13(4):2020-30. doi: 10.1128/mcb.13.4.2020-2030.1993. Mol Cell Biol. 1993. PMID: 8455595 Free PMC article.

5

Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells.

Lira SA, Zalamea P, Heinrich JN, Fuentes ME, Carrasco D, Lewin AC, Barton DS, Durham S, Bravo R. Lira SA, et al. Among authors: heinrich jn. J Exp Med. 1994 Dec 1;180(6):2039-48. doi: 10.1084/jem.180.6.2039. J Exp Med. 1994. PMID: 7964481 Free PMC article.

6

Monocyte chemotactic protein-2, monocyte chemotactic protein-3, and fibroblast-induced cytokine. Three new chemokines induce chemotaxis and activation of basophils.

Alam R, Forsythe P, Stafford S, Heinrich J, Bravo R, Proost P, Van Damme J. Alam R, et al. J Immunol. 1994 Oct 1;153(7):3155-9. J Immunol. 1994. PMID: 7522251

7

Transcriptional activity of Drosophila melanogaster ecdysone receptor isoforms and ultraspiracle in Saccharomyces cerevisiae.

Dela Cruz FE, Kirsch DR, Heinrich JN. Dela Cruz FE, et al. Among authors: heinrich jn. J Mol Endocrinol. 2000 Apr;24(2):183-91. doi: 10.1677/jme.0.0240183. J Mol Endocrinol. 2000. PMID: 10750019

8

Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists.

Heinrich JN, Butera JA, Carrick T, Kramer A, Kowal D, Lock T, Marquis KL, Pausch MH, Popiolek M, Sun SC, Tseng E, Uveges AJ, Mayer SC. Heinrich JN, et al. Eur J Pharmacol. 2009 Mar 1;605(1-3):53-6. doi: 10.1016/j.ejphar.2008.12.044. Epub 2009 Jan 11. Eur J Pharmacol. 2009. PMID: 19168056

9

D2 receptor partial agonists: treatment of CNS disorders of dopamine function.

Kehne JH, Andree TH, Heinrich JN. Kehne JH, et al. Among authors: heinrich jn. Curr Top Med Chem. 2008;8(12):1068-88. doi: 10.2174/156802608785161394. Curr Top Med Chem. 2008. PMID: 18691133 Review.

10

Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.

Heinrich JN, Brennan J, Lai MH, Sullivan K, Hornby G, Popiolek M, Jiang LX, Pausch MH, Stack G, Marquis KL, Andree TH. Heinrich JN, et al. Eur J Pharmacol. 2006 Dec 15;552(1-3):36-45. doi: 10.1016/j.ejphar.2006.08.063. Epub 2006 Sep 14. Eur J Pharmacol. 2006. PMID: 17056032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters